{"id":250150,"date":"2022-12-27T00:00:00","date_gmt":"2022-12-27T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/products\/research-reports\/report\/exincg0003-2022-biopharma-ischemic-stroke-executive-insights-ischemic\/"},"modified":"2026-03-31T10:35:29","modified_gmt":"2026-03-31T10:35:29","slug":"exincg0003-2022-biopharma-ischemic-stroke-executive-insights-ischemic-stroke-executive-insights-us","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/exincg0003-2022-biopharma-ischemic-stroke-executive-insights-ischemic-stroke-executive-insights-us\/","title":{"rendered":"Ischemic Stroke – Executive Insights – Ischemic Stroke – Executive Insights (US)"},"content":{"rendered":"","protected":false},"template":"","class_list":["post-250150","report","type-report","status-publish","hentry","report-gateway-biopharma","biopharma-therapy-areas-ischemic-stroke","biopharma-therapy-areas-neurology","biopharma-geography-us","biopharma-date-960"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250150","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250150\/revisions"}],"predecessor-version":[{"id":281952,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/250150\/revisions\/281952"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=250150"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}